Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Imatinib-Mesylate Taj API

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Imatinib Mesylate Manufacturers in India Suppliers Imatinib Mesylate Dossage Exporters Distributors Imatinib Mesylate api active pharmaceuticals ingredients Imatinib Mesylate manufacturers Side Effects bulk drugs raw material Dossage Imatinib Mesylate companies Side Effects Dossage Importers Imatinib Mesylate Dossage Imatinib Mesylate Exporters Imatinib Mesylate exporters Dossage FDA Dossage Imatinib Mesylate Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Imatinib Mesylate manufacturing pharmaceutical drugs pharmaceutical intermediates Imatinib Mesylate pharmaceutical chemicals pharmaceutical raw materials Imatinib Mesylate active pharmaceutical ingredients Imatinib Mesylate committee active pharmaceutical ingredients manufacturer Imatinib Mesylate Active Pharmaceutical Ingredients manufacturer Imatinib Mesylate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Imatinib Mesylate, Imatinib Mesylate manufacturer India, Imatinib Mesylate product, Imatinib Mesylate products, Api preparation, Certificate of Analysis API manufacturer product, Imatinib Mesylate anti ulcer product, Certificate of Origin COA Imatinib Mesylate COS Imatinib Mesylate, pharmaceutical generic, pharmaceutical drug, medical, Imatinib Mesylate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Imatinib Mesylate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Imatinib Mesylate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Imatinib Mesylate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Imatinib Mesylate ingredients, api, HIV Imatinib Mesylate, tablets, capsules, syrup & protein Imatinib Mesylate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Imatinib Mesylate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Imatinib Mesylate WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

pharma Imatinib Mesylate

 








 

 

HOME >> API >> API List 2 >> Imatinib Mesylate >> Dosage

Imatinib Mesylate CAS Registry Number 220127-57-1

DOSAGE
Imatinib Mesylate

Imatinib mesylate is a pill, taken by mouth, once or twice daily.
Imatinib mesylate should be taken with a large glass of water, after a meal.
The amount of Imatinib mesylate that you will receive depends on many factors, including your general health or other health problems, and the type of cancer or condition being treated. Your doctor will determine your dose and schedule.

Patients with Philadelphia chromosome positive chronic myeloid leukemia in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy.Pediatric patients with Ph+ CML in chronic phase who are newly diagnosed or whose disease has recurred after stem cell transplant or who are resistant to interferon-alpha therapy. There are no controlled trials in pediatric patients demonstrating a clinical benefit, such as improvement in disease-related symptoms or increased survival.Adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemiaAdult patients with myelodysplastic/ myeloproliferative diseases associated with PDGFR (platelet-derived growth factor receptor) gene re-arrangementsAdult patients with aggressive systemic mastocytosis without the D816V c-Kit mutation or with c-Kit mutational status unknown

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE >>
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo
 

Imatinib Mesylate

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin

Gemcitabine Hcl

Glimepiride

Granisetron Hcl

Ibandronate Sodium

Imatinib Mesylate

Irbesartan

Irinotecan Hcl

Isradipine

Lamotrigine

Lercanidipine

Letrozole

Losartan Potassium

Loteprednol Etabonate

Magnesium Valproate

Meloxicam

Memantine Hcl

Mesalazine

Metamizol Magnesium

Metaxalone

Metformin Hcl

Metoprolol Tartrate

Mifepristone

Mirtazapine

Modafinil

Mometasone Furoate

Naltrexone Hcl

Netaglinide

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.